Biocad Is A Prominent Russian Biotechnology Company Focused On Full Cycle Drug Developmentfrom Molecular Research To Mass Production And Commercializationwith A Workforce Of 2 600 To 3 000 Professionalsabout One Third Are Dedicated To Research And Scientific Rolesthe Company Operates Advanced R&D Centers And Manufacturing Facilitiesensuring Compliance With International Standards In Clinical Trials Biocad Conducts Clinical Trials At Approved Healthcare Facilitiesproviding Participants Access To Innovative Therapiesits Research Efforts Emphasize Genetic Engineeringpreclinical Studiesand Drug Discoverythe Company Has A Diverse Portfolio Of 68 Medical Productsincluding 13 Original Drugs And Over 40 Candidates In Developmentwith A Focus On Oncologyautoimmune Diseasesand Orphan Genetic Disordersbiocad Also Maintains International Offices In Brazilvietnamand The Uae To Support Market Expansion And Collaborationthe Company Is Committed To Sustainability And Publishes Annual Reports On Its Contributions To Environmental And Social Goalsincluding Equitable Healthcare Accessit Also Provides Educational Resources To Enhance Public Understanding Of Clinical Trials
